[14C]-IDV184001AN

· Indivior Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for [14C]-IDV184001AN, covering 2025-02-13 to 2025-02-13. Get the full timeline:

Most recent: Clinical Trial Update: Single Dose Study of [14C]-IDV184001AN ([14C]-IDV184001) in Healthy Adult Male Participants [Phase 1]